Daraxonrasib, a new pancreatic cancer drug, extended survival in late-stage patients and may offer a...
Pancreatic Cancer Breakthrough Drug Extends Lives of Patients: 'I Had a Full Year of Normalcy'
Daraxonrasib, a new pancreatic cancer drug, extended survival in late-stage patients and may offer an option beyond chemotherapy.
Author: People.com
Read Original Article